NCT07894302
Improving Women's Fertility Awareness and Reducing Anxiety Through Ovarian Reserve Screening and AI Counseling
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Arms and interventions
Participants undergo Anti-Müllerian Hormone (AMH) blood testing. Personalized biomarker results and tailored fertility counseling are delivered via the interactive AI conversational agent ("Shelby"). Outcomes are assessed post-intervention.
Participants undergo Anti-Müllerian Hormone (AMH) blood testing. Biomarker results are delivered via a conventional static laboratory report displaying reference ranges without AI interaction.
Participants do not undergo AMH blood testing. If requested, participants are provided digital access to the AI conversational agent ("Shelby") for general fertility and reproductive health education without personalized biomarker data.
Participants do not undergo AMH blood testing and serve as the standard control. If requested, participants are provided access to standard informational websites/materials regarding general reproductive health.
Behavioral: AI-Enabled Fertility Counseling, Standard Educational Materials or PDF laboratory reports
Sites
1 site in 1 country
- City University of Hong KongHong Kong, Kowloon, Hong Kong